Dr. Hugo Yamada, MD

NPI: 1932196904
Total Payments
$7,037
2023 Payments
$20.42
Companies
36
Transactions
458
Medicare Patients
3,087
Medicare Billing
$263,956

Payment Breakdown by Category

Food & Beverage$6,953 (98.8%)
Education$84.23 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,953 450 98.8%
Education $84.23 8 1.2%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,119 72 $0 (2020)
AstraZeneca Pharmaceuticals LP $864.83 39 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $668.71 35 $0 (2020)
PFIZER INC. $645.31 71 $0 (2020)
Novo Nordisk Inc $639.18 34 $0 (2020)
Amgen Inc. $489.54 26 $0 (2019)
Lilly USA, LLC $385.39 25 $0 (2020)
SANOFI-AVENTIS U.S. LLC $349.74 18 $0 (2020)
Merck Sharp & Dohme LLC $334.45 39 $0 (2022)
E.R. Squibb & Sons, L.L.C. $231.05 14 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $20.42 1 Dexcom, Inc. ($20.42)
2022 $21.70 1 Merck Sharp & Dohme LLC ($21.70)
2020 $363.12 22 AstraZeneca Pharmaceuticals LP ($58.06)
2019 $2,176 132 Janssen Pharmaceuticals, Inc ($401.48)
2018 $2,330 148 Janssen Pharmaceuticals, Inc ($368.41)
2017 $2,126 154 AstraZeneca Pharmaceuticals LP ($350.75)

All Payment Transactions

458 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
03/09/2023 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $20.42 General
Category: Endocrinology
06/16/2022 Merck Sharp & Dohme LLC VERQUVO (Drug) Education In-kind items and services $21.70 General
Category: CARDIOVASCULAR
03/10/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $22.66 General
Category: Endocrinology
03/09/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $17.49 General
03/04/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $23.90 General
Category: Cardiovascular and Metabolism
03/03/2020 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT Food and Beverage In-kind items and services $17.62 General
Category: RESPIRATORY
03/03/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.72 General
Category: GASTROENTEROLOGY
03/02/2020 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.63 General
Category: DIABETES
02/20/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $11.24 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
02/11/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $18.08 General
Category: Endocrinology
02/10/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.82 General
Category: GASTROENTEROLOGY
02/05/2020 Eisai Inc. Lenvima (Drug) Food and Beverage Cash or cash equivalent $17.29 General
Category: Oncology
02/05/2020 Novo Nordisk Inc Tresiba (Drug), Victoza Food and Beverage In-kind items and services $15.19 General
Category: Diabetes
02/04/2020 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $11.24 General
Category: Neuroscience
01/31/2020 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $17.05 General
Category: VACCINES
01/29/2020 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), GLYXAMBI, SYNJARDY Food and Beverage In-kind items and services $20.09 General
Category: DIABETES
01/27/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.67 General
Category: Cardiovascular and Metabolism
01/23/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $14.96 General
Category: Cardiovascular & Metabolism
01/23/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $11.30 General
Category: CARDIOVASCULAR
01/22/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $11.89 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
01/15/2020 GlaxoSmithKline, LLC. ANORO ELLIPTA (Drug) Food and Beverage In-kind items and services $19.51 General
Category: RESPIRATORY
01/08/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $19.12 General
Category: Cardiovascular
01/08/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $15.15 General
Category: Diabetes
01/08/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $14.50 General
Category: Central Nervous System
12/29/2019 Medtronic MiniMed, Inc. Minimed 670G System (Device) Food and Beverage In-kind items and services $16.71 General
Category: Durable Pump

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 635 912 $145,415 $60,578
2022 11 673 946 $150,186 $63,864
2021 10 1,013 1,262 $169,501 $76,222
2020 12 766 1,092 $169,296 $63,291
Total Patients
3,087
Total Services
4,212
Medicare Billing
$263,956
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 127 337 $75,488 $27,985 37.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 86 86 $20,898 $11,290 54.0%
99497 Advance care planning, first 30 minutes Office 2023 91 92 $16,192 $7,095 43.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 96 $14,496 $5,349 36.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 18 20 $6,020 $2,717 45.1%
90480 Admn sarscov2 vacc 1 dose Office 2023 44 44 $2,640 $1,757 66.5%
G0008 Administration of influenza virus vaccine Office 2023 54 56 $2,968 $1,757 59.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 24 30 $2,460 $1,217 49.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 78 99 $3,564 $1,004 28.2%
G0009 Administration of pneumococcal vaccine Office 2023 13 13 $689.00 $407.81 59.2%
91322 Sarscov2 vac 50 mcg/0.5ml im Office 2023 39 39 $0.39 $0.37 94.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 133 298 $66,752 $23,723 35.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 92 92 $22,356 $12,405 55.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 108 187 $28,237 $12,101 42.9%
99497 Advance care planning, first 30 minutes Office 2022 93 94 $16,544 $7,650 46.2%
G0008 Administration of influenza virus vaccine Office 2022 70 73 $3,869 $2,238 57.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 11 11 $3,311 $1,555 47.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 80 105 $3,780 $1,022 27.0%
0134A Fee covid-19 vac 14 res Office 2022 26 26 $1,560 $971.04 62.2%
0004A Adm sarscov2 30mcg/0.3ml bst Office 2022 19 19 $1,140 $774.20 67.9%
G0009 Administration of pneumococcal vaccine Office 2022 25 25 $1,325 $771.76 58.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2022 16 16 $1,312 $652.15 49.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 142 313 $70,112 $24,109 34.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 117 117 $28,431 $16,139 56.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 75 121 $18,271 $8,715 47.7%

About Dr. Hugo Yamada, MD

Dr. Hugo Yamada, MD is a Internal Medicine healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932196904.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hugo Yamada, MD has received a total of $7,037 in payments from pharmaceutical and medical device companies, with $20.42 received in 2023. These payments were reported across 458 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,953).

As a Medicare-enrolled provider, Yamada has provided services to 3,087 Medicare beneficiaries, totaling 4,212 services with total Medicare billing of $263,956. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Lincoln, RI
  • Active Since 10/04/2005
  • Last Updated 07/25/2012
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1932196904

Products in Payments

  • XARELTO (Drug) $840.94
  • FARXIGA (Drug) $558.95
  • JARDIANCE (Drug) $433.97
  • CHANTIX (Drug) $342.50
  • JANUVIA (Drug) $312.75
  • SYMBICORT (Drug) $288.39
  • ELIQUIS (Drug) $279.97
  • INVOKANA (Drug) $278.16
  • Victoza (Drug) $267.57
  • TRADJENTA (Drug) $217.22
  • Prolia (Biological) $201.01
  • TRULICITY (Drug) $185.33
  • TOUJEO (Drug) $181.67
  • Ozempic (Drug) $169.30
  • PREVNAR - 13 (Biological) $136.71
  • Tresiba (Drug) $131.23
  • EMGALITY (Drug) $121.78
  • ENTRESTO (Drug) $110.51
  • Aimovig (Biological) $103.10
  • VIAGRA (Drug) $95.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Lincoln